Stephanie Quattrocki, LCPC, is a clinician and consultant specializing in psychedelic integration, ketamine-assisted psychotherapy, and preparation-to-integration models.

Her work includes psychedelic clinical trial experience through Rush University Medical Center sister site with investigational treatment programs, including Compass Pathways’ COMP360 and Helus Pharma/Cybin compounds.

She supports clinical research evaluating emerging breakthrough therapies with a focus on therapist preparation, integration, safety, and continuity of care.

She has helped develop and operationalize psychedelic therapy services, including training and implementation support for therapists, clinical team members, and operational teams within a multi-location psychiatric and behavioral health system, and is involved in building psychedelic care infrastructure and advocacy in Chicago.

An important part of her work centers on preparing licensed therapists to protect patient safety and translate psychedelic experiences into sustained therapeutic change. While infrastructure and advocacy are passions, Stephanie’s work remains grounded in a fundamental commitment to relieve human suffering.